Information Provided By: 
Fly News Breaks for February 8, 2017
CAH
Feb 8, 2017 | 07:50 EDT
Leerink analyst David Larsen raised his price target for Cardinal Health to $81 from $75 as he believes that buy-side economics for generics are stabilizing, sell-side pressures are now accounted for in 2017 guidance, and brand inflation seems to be in-line with expectations. He reiterates a Market Perform rating on the shares.
News For CAH From the Last 2 Days
